Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.

Authors: Clarke, John D; Novak, Petr; Lake, April D; Shipkova, Petia; Aranibar, Nelly; Robertson, Donald; Severson, Paul L; Reily, Michael D; Futscher, Bernard W; Lehman-McKeeman, Lois D; Cherrington, Nathan J

Published In Dig Dis Sci, (2014 Feb)

Abstract: BACKGROUND: The worldwide prevalences of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are estimated to range from 30 to 40 % and 5-17 %, respectively. Hepatocellular carcinoma (HCC) is primarily caused by hepatitis B infection, but retrospective data suggest that 4-29 % of NASH cases will progress to HCC. Currently the connection between NASH and HCC is unclear. AIMS: The purpose of this study was to identify changes in expression of HCC-related genes and metabolite profiles in NAFLD progression. METHODS: Transcriptomic and metabolomic datasets from human liver tissue representing NAFLD progression (normal, steatosis, NASH) were utilized and compared to published data for HCC. RESULTS: Genes involved in Wnt signaling were downregulated in NASH but have been reported to be upregulated in HCC. Extracellular matrix/angiogenesis genes were upregulated in NASH, similar to reports in HCC. Iron homeostasis is known to be perturbed in HCC and we observed downregulation of genes in this pathway. In the metabolomics analysis of hepatic NAFLD samples, several changes were opposite to what has been reported in plasma of HCC patients (lysine, phenylalanine, citrulline, creatine, creatinine, glycodeoxycholic acid, inosine, and alpha-ketoglutarate). In contrast, multiple acyl-lyso-phosphatidylcholine metabolites were downregulated in NASH livers, consistent with observations in HCC patient plasma. CONCLUSIONS: These data indicate an overlap in the pathogenesis of NAFLD and HCC where several classes of HCC related genes and metabolites are altered in NAFLD. Importantly, Wnt signaling and several metabolites are different, thus implicating these genes and metabolites as mediators in the transition from NASH to HCC.

PubMed ID: 24048683 Exiting the NIEHS site

MeSH Terms: Biomarkers, Tumor/genetics*; Biomarkers, Tumor/metabolism*; Carcinoma, Hepatocellular/genetics*; Carcinoma, Hepatocellular/metabolism*; Carcinoma, Hepatocellular/pathology; Cell Transformation, Neoplastic/genetics; Cell Transformation, Neoplastic/metabolism; Cell Transformation, Neoplastic/pathology; Cluster Analysis; Databases, Genetic; Fatty Liver/genetics*; Fatty Liver/metabolism*; Fatty Liver/pathology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms/genetics*; Liver Neoplasms/metabolism*; Liver Neoplasms/pathology; Metabolomics; Non-alcoholic Fatty Liver Disease; Signal Transduction/genetics

Back
to Top